Medicare Enrolled
Dr. Mauna Pandya, MD
Hematology & Oncology · Oak Lawn, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pandya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pandya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pandya
Dr. Mauna Pandya is a hematology & oncology specialist in Oak Lawn, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pandya performed 41,516 Medicare services across 1,496 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pandya received a total of $15,546 from 91 pharmaceutical and/or device companies across 788 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pandya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in IL
$15,546 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,516
Medicare services
Top 23% in IL for hematology & oncology
1,496
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,185 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
21,000 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 6,400 | $44 | $147 |
| Denosumab injection (Prolia/Xgeva) | 3,840 | $18 | $71 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
3,750 | $0 | $6 |
| Iron infusion (Monoferric) | 1,400 | $17 | $75 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,334 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 660 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
364 | $95 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
298 | $141 | $530 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
290 | $99 | $380 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
231 | $108 | $686 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
215 | $66 | $270 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
204 | $13 | $105 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
191 | $6 | $462 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
187 | $11 | $93 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
180 | $65 | $270 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
162 | $24 | $152 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
105 | $142 | $750 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
98 | $51 | $304 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
71 | $59 | $205 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
61 | $22 | $90 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
58 | $24 | $156 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
57 | $1 | $19 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
52 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $54 | $334 |
| New patient office visit, complex (60-74 min) | 31 | $173 | $760 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $125 | $620 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
28 | $104 | $510 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
26 | $1 | $9 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
24 | $1,300 | $4,120 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $26 | $249 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 24 | $414 | $638 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
23 | $2 | $19 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
21 | $46 | $281 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
17 | $240 | $758 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
17 | $0 | $3 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.4% high complexity
40.7% medium
4.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,546
Total received (2018-2024)
Avg $2,221/year across 7 years
Top 25% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
91
Companies
788
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,405 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$141 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,778
2023
$3,376
2022
$2,613
2021
$1,725
2020
$635
2019
$1,723
2018
$1,696
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$297
PFIZER INC.
$230
E.R. Squibb & Sons, L.L.C.
$229
Ipsen Biopharmaceuticals, Inc
$227
AstraZeneca Pharmaceuticals LP
$224
Alexion Pharmaceuticals, Inc.
$214
Regeneron Healthcare Solutions, Inc.
$145
Gilead Sciences, Inc.
$143
Janssen Biotech, Inc.
$133
Merck Sharp & Dohme LLC
$123
Genentech USA, Inc.
$102
GE HEALTHCARE
$99
GENZYME CORPORATION
$98
Takeda Pharmaceuticals U.S.A., Inc.
$89
Eisai Inc.
$87
Lilly USA, LLC
$82
ABBVIE INC.
$75
GlaxoSmithKline, LLC.
$71
Pharmacosmos Therapeutics Inc.
$69
TerSera Therapeutics LLC
$67
Daiichi Sankyo Inc.
$57
JAZZ PHARMACEUTICALS INC.
$57
Fresenius Kabi USA, LLC
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
PUMA BIOTECHNOLOGY, INC.
$46
Tempus AI, Inc
$44
Exelixis Inc.
$44
BeiGene USA, Inc.
$43
Mirati Therapeutics, Inc.
$40
Celgene Corporation
$40
ADC Therapeutics America, Inc.
$39
Agios Pharmaceuticals, Inc.
$34
Blueprint Medicines Corporation
$29
Amneal Pharmaceuticals LLC
$26
Deciphera Pharmaceuticals Inc.
$26
Immunocore Limited
$25
Spectrum Pharmaceuticals Inc.
$25
Sumitomo Pharma America, Inc.
$25
Karyopharm Therapeutics Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$24
Aveo Pharmaceuticals, Inc.
$24
Astellas Pharma US Inc
$22
ImmunoGen, Inc.
$22
EMD Serono, Inc.
$22
Apellis Pharmaceuticals, Inc.
$21
Blue Earth Diagnostics Limited
$20
Fennec Pharmaceuticals, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
TAIHO ONCOLOGY, INC.
$19
Incyte Corporation
$16
ARRAY BIOPHARMA INC
$10
Top 3 companies account for 20.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,145
E.R. Squibb & Sons, L.L.C.
$1,011
Janssen Biotech, Inc.
$879
AstraZeneca Pharmaceuticals LP
$759
PFIZER INC.
$600
Merck Sharp & Dohme Corporation
$595
Amgen Inc.
$583
Merck Sharp & Dohme LLC
$571
Genentech USA, Inc.
$548
Lilly USA, LLC
$525
Astellas Pharma US Inc
$444
Gilead Sciences, Inc.
$382
Celgene Corporation
$360
Ipsen Biopharmaceuticals, Inc
$333
Eisai Inc.
$330
Alexion Pharmaceuticals, Inc.
$328
Daiichi Sankyo Inc.
$320
Takeda Pharmaceuticals U.S.A., Inc.
$310
GENZYME CORPORATION
$299
GlaxoSmithKline, LLC.
$223
Regeneron Healthcare Solutions, Inc.
$191
Janssen Pharmaceuticals, Inc
$180
Exelixis Inc.
$178
Octapharma USA, Inc.
$177
Dova Pharmaceuticals
$177
Incyte Corporation
$170
BeiGene USA, Inc.
$166
Global Blood Therapeutics, Inc.
$158
EMD Serono, Inc.
$147
JAZZ PHARMACEUTICALS INC.
$136
Pharmacyclics LLC, An AbbVie Company
$134
Seagen Inc.
$133
ABBVIE INC.
$124
Coherus Biosciences Inc.
$116
GE HEALTHCARE
$115
MorphoSys, US Inc.
$107
EISAI INC.
$104
Myriad Genetic Laboratories, Inc.
$100
G1 Therapeutics, Inc.
$99
Bayer HealthCare Pharmaceuticals Inc.
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Novo Nordisk Inc
$88
Pharmacosmos Therapeutics Inc.
$87
Mirati Therapeutics, Inc.
$82
Taiho Oncology, Inc.
$79
Deciphera Pharmaceuticals Inc.
$75
Foundation Medicine, Inc.
$74
Clovis Oncology, Inc.
$71
Fresenius Kabi USA, LLC
$71
Kite Pharma, Inc.
$70
TerSera Therapeutics LLC
$67
PUMA BIOTECHNOLOGY, INC.
$61
Genmab U.S., Inc.
$58
AbbVie, Inc.
$58
Puma Biotechnology, Inc.
$56
GE HealthCare
$53
Teva Pharmaceuticals USA, Inc.
$53
Agios Pharmaceuticals, Inc.
$52
Sobi, Inc
$52
Blueprint Medicines Corporation
$52
Rigel Pharmaceuticals, Inc.
$50
Pharmacyclics LLC, an AbbVie Company
$49
Karyopharm Therapeutics Inc.
$46
Sumitomo Pharma America, Inc.
$45
Tempus AI, Inc
$44
ADC Therapeutics America, Inc.
$39
SERVIER PHARMACEUTICALS LLC
$36
AMAG Pharmaceuticals, Inc.
$35
TOLMAR Pharmaceuticals, Inc.
$33
Kyowa Kirin, Inc.
$28
Amneal Pharmaceuticals LLC
$26
Immunocore Limited
$25
RECORDATI_RARE_DISEASES_INC.
$25
Spectrum Pharmaceuticals Inc.
$25
Jazz Pharmaceuticals Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$24
Aveo Pharmaceuticals, Inc.
$24
Secura Bio, Inc.
$24
Myovant Sciences Inc.
$23
ImmunoGen, Inc.
$22
Sun Pharmaceutical Industries Inc.
$22
Seattle Genetics, Inc.
$21
Apellis Pharmaceuticals, Inc.
$21
Blue Earth Diagnostics Limited
$20
Verastem, Inc.
$20
Fennec Pharmaceuticals, Inc.
$19
TAIHO ONCOLOGY, INC.
$19
Progenics Pharmaceuticals, Inc.
$17
Tactile Systems Technology Inc
$16
Sysmex Inostics Inc
$12
ARRAY BIOPHARMA INC
$10
Top 3 companies account for 19.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · AFINITOR · ALIMTA · ALUNBRIG · ASPARLAS · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BALVERSA · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Novoeight · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYLVANT · Stimufend · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEPMETKO · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · Vectibix · Venclexta · Vitrakvi · WAINUA · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
345
Per 100K population
6.7
County median income
$81,797
Nearest hospital
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pandya is a mixed practice specialist, with above-average Medicare volume (top 23% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pandya experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Pandya performed 21,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pandya receive payments from pharmaceutical companies?
Yes. Dr. Pandya received a total of $15,546 from 91 companies across 788 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pandya's costs compare to other hematology & oncology specialists in Oak Lawn?
Dr. Pandya's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pandya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Oak Lawn
Browse hematology & oncology specialists in Oak Lawn ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology